Get email updates from SABCSMeetingNews.org
Subscribe to get regular news updates from SABCS.org and SABCS Meeting News.
DECEMBER 6–10, 2022
Henry B. Gonzalez Convention Center
|
San Antonio, TX
-
Expert who changed the standard of breast cancer care honored with the Brinker Award for Scientific Distinction in Clinical Research
Norman Wolmark, MD, FACS, FRCSC, will receive the Brinker Award for Scientific Distinction in Clinical Research on Friday, and will deliver the lecture “The Contribution of NSABP Clinical Trials to the Management of Early Breast Cancer: PAST AS PROLOGUE.”
-
General Session 2 features latest findings from DESTINY-Breast02/03, TRIO-US B-12 TALENT trials
Wednesday’s General Session included data from three trials looking at the use of the antibody drug conjugate trastuzumab deruxtecan (T-DXd) in HER2-positive metastatic and HER-2-low, HR-positive early-stage breast cancer.
-
Osborne Symposium highlights growing understanding of HER2, ER crosstalk
C. Kent Osborne, MD, opened a session named in his honor on Wednesday as experts discussed the interplay between estrogen receptors and HER2 signaling pathways.
-
McGuire Lecturer, Jeffrey Rosen, PhD, reviews work with preclinical models in breast cancer research
Jeffrey Rosen, PhD, a pioneer of mouse modeling and mouse mammary tumorigenesis, received the William L. McGuire Memorial Lecture Award.
-
Debate to weigh differences, similarities of CDK4/6 inhibitors
Ruth O’Regan, MD, and Debra Patt, MD, PhD, MBA, will take sides on the impacts of CDK4/6 inhibitors during a Thursday morning debate session.
-
Panel to discuss evolving role of liquid biopsies in breast cancer treatment and research
Nicholas Turner, MD, PhD, will moderate a Thursday afternoon session that will provide an update on the current uses of liquid biopsies in metastatic disease as well as growing applications for ctDNA in clinical trials.
-
Management of Hereditary Risk: Moderate-Risk Genes and New Approaches: Presenter Profiles
Madeleine M.A. Tilanus-Linthorst, MD, PhD, and Joanne Kotsopoulos, MSc, PhD, preview their Thursday afternoon presentations.
-
What ctDNA Can Tell Us: Presenter Profile
Minetta C. Liu, MD, previews a Thursday afternoon presentation on using ctDNA in detecting disease.
-
New Translational Controversies session to feature ‘lightning discussions’ on important topics
Komal Jhaveri, MD, FACP, will moderate discussions about current controversies in translational medicine for breast cancer.
-
Panel to discuss approaches to managing moderate hereditary risk for breast cancer
Seema A. Khan, MD, will lead a session on Thursday afternoon looking at evolving evidence on managing patients at moderate genetic breast cancer risk.